Cidara Therapeutics Inc
XNAS: CDTX
Cidara Therapeutics Inc Live Stock Price Today, Share Analysis and Chart
about
Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. Its clinical-stage asset is CD388, a DFC intended for influenza prophylaxis. The Company's portfolio comprise...
Read More
62.96
0.81
(1.30%)
829.9K
XNAS Volume
XNAS 09 Sep, 2025 5:30 PM (EDT)
Board Meeting
The latest board meeting for Cidara Therapeutics Inc took place on 09 Sep 2025, for the purpose of Morgan Stanley 23rd Annual Global Healthcare Conference
See details
Not Eligible
Expensive Valuation
Technically Moderately Bullish
Cidara Therapeutics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..